Skip to content

Clomiphene Citrate for Poor Responder women undergoing in vitro fertilisation (IVF)/intracytoplasmic sperm injection (ICSI) treatment cycles

Clomiphene Citrate for Poor Responder women undergoing in vitro fertilisation (IVF)/intracytoplasmic sperm injection (ICSI) treatment cycles: randomised controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN58828341
Enrollment
70
Registered
2011-03-28
Start date
2008-04-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Poor ovarian response Pregnancy and Childbirth Fertility

Interventions

Control group: Thirty-five women underwent COH with a long GnRH agonist protocol: Triptorelin acetate SC (Decapeptyl® 0.1 mg, Ferring, Denmark) was administrated in the midluteal phase at a daily dos

Sponsors

Egyptian International Fertility and IVF Center (EIFC) (Eygpt)
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Women 20 - 42 years old 2. History of primary or secondary infertility (defined as the inability to conceive after 2 years of unprotected intercourse) 3. Normal menstrual cycle 4. Body mass index (BMI) less than 27 kg/m^2 5. Not taking medication for at least 1.5 months 6. Both ovaries are present 7. Basal FSH level on day 3 is less than 10 IU/L

Exclusion criteria

Exclusion criteria: 1. Clinically or medically significant systemic disease 2. Hypothalamic amenorrhoea 3. Cycle cancellation due to poor ovarian response; patients were defined as poor responders by number of dominant follicles on HCG day and number of mature oocytes less than 3

Design outcomes

Primary

MeasureTime frame
1. Duration of stimulation (i.e. duration and amount of HMG used) 2. Consumption of gonadotrophins 3. Cycle cancellation rate 4. Number of mature follicles recruited 5. Total oocytes retrieved

Secondary

MeasureTime frame
1. Laboratory outcomes 2. Implantation rate 3. Clinical pregnancy rates, 7 weeks from positive pregnancy test

Countries

Egypt

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026